Position in ARGX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$23,110,220
-$27,669,703 QoQ
Shares Held
31,647
-47.6% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 73.6278320219926.ToString("F0")%
Shared 0.ToString("F0")%
None 26.372167978007393.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Derivatives in ARGX
reported options exposure · as of Jun 30, 2025CallValue
$1,102,440
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. ARGX ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ARGX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,110,220 | 31,647 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $50,779,923 | 60,384 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $39,675,563 | 53,793 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $37,635,095 | 68,276 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $1,102,440 | 2,000 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,183,730 | 2,000 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $60,452,497 | 102,139 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,238,500 | 19,900 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,039,166 | 1,917 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $949,526 | 2,208 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,211,869 | 3,078 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $630,371 | 1,657 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,474,890 | 3,000 | Call | Defined | 2023-11-09 | |
| 2023-09-30 | $842,652 | 1,714 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,169,190 | 3,000 | Call | Defined | 2023-08-11 | |
| 2023-06-30 | $787,643 | 2,021 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,117,740 | 3,000 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $571,164 | 1,533 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,470,995 | 3,883 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $670,440 | 1,899 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,019,049 | 5,329 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,635,827 | 5,188 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,847,044 | 8,130 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,778,322 | 12,511 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,712,640 | 9,010 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,494,816 | 5,428 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $622,588 | 2,117 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $532,652 | 2,029 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $515,325 | 2,288 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $356,593 | 2,707 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||